Literature DB >> 2030103

Antidepressant treatment and side effect considerations.

G D Tollefson1.   

Abstract

Many antidepressant drugs are available today, including both the first-generation and second-generation antidepressants. While antidepressants are similar in terms of drug efficacy, onset of action, and latency to treatment response, their potential side effect and toxicity profiles are quite different. These factors must be weighed before treatment of depression is begun in an effort to prescribe the compound that is most beneficial, i.e., clinically effective while exhibiting the fewest negative aspects. Determination of patients' "at-risk" profile for drug side effects is best done by a careful analysis of their medical history and concomitant drug therapies. The relative toxicity index for antidepressants should also be reviewed carefully with the goal of avoiding the unwanted sequelae of antidepressant toxicity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2030103

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  8 in total

Review 1.  Risks and benefits of selective serotonin reuptake inhibitors in the treatment of depression.

Authors:  P Mourilhe; P E Stokes
Journal:  Drug Saf       Date:  1998-01       Impact factor: 5.606

Review 2.  Drug-induced Pisa syndrome (pleurothotonus): epidemiology and management.

Authors:  Toshihito Suzuki; Hisashi Matsuzaka
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

3.  Cost analysis of paroxetine versus imipramine in major depression.

Authors:  J D Bentkover; J P Feighner
Journal:  Pharmacoeconomics       Date:  1995-09       Impact factor: 4.981

4.  Neurochemical and behavioural effects of hypidone hydrochloride (YL-0919): a novel combined selective 5-HT reuptake inhibitor and partial 5-HT1A agonist.

Authors:  Li-Ming Zhang; Xiao-Yun Wang; Nan Zhao; Yu-Lu Wang; Xiao-Xu Hu; Yu-Hua Ran; Yan-Qin Liu; You-Zhi Zhang; Ri-Fang Yang; Yun-Feng Li
Journal:  Br J Pharmacol       Date:  2017-03-21       Impact factor: 8.739

5.  Role of newer antidepressants.

Authors:  M Zetin
Journal:  West J Med       Date:  1994-01

Review 6.  Neuroimmune mechanisms of psychostimulant and opioid use disorders.

Authors:  Rebecca S Hofford; Scott J Russo; Drew D Kiraly
Journal:  Eur J Neurosci       Date:  2018-09-26       Impact factor: 3.386

7.  Pharmacologic specificity of antidepressive activity by monoaminergic neural transplants.

Authors:  D D Dougherty; C E Sortwell; J Sagen
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

Review 8.  Antidepressant toxicity and the need for identification and concentration monitoring in overdose.

Authors:  B M Power; L P Hackett; L J Dusci; K F Ilett
Journal:  Clin Pharmacokinet       Date:  1995-09       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.